Steven A. Shallcross - Apr 29, 2025 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Role
CEO and CFO, Director
Signature
/s/ Steven A. Shallcross
Stock symbol
TOVX
Transactions as of
Apr 29, 2025
Transactions value $
$0
Form type
4
Date filed
5/1/2025, 04:01 PM
Previous filing
Dec 15, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOVX Stock Options (right to buy) Award $0 +190K $0.00 190K Apr 29, 2025 Common Stock 190K $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest pro rata on a monthly basis over 36 months.